Loading organizations...
§ Private Profile · 1247 S Cedar Crest Blvd Ste 107, Allentown, Pennsylvania, 18103, United States
Mental health care provider offering neuroscience-driven virtual and in-person treatments for youth, focused on developmental challenges.
Based in Pittsburgh, Pennsylvania, Blackbird Health provides neuroscience-driven mental health care for children and young adults through a combination of virtual and in-person treatments. The company utilizes computational tools and machine learning to diagnose root causes of social, emotional, and developmental challenges, operating as an in-network provider with major insurance carriers and employers. Blackbird Health currently employs more than 40 providers across three physical clinics in the Mid-Atlantic region, delivering approximately 75% of its services via telehealth. The organization has raised approximately $23 million in total funding to date, including a recent $17 million Series A round led by Define Ventures with participation from Frist Cressey Ventures and GreyMatter. The clinical model was originally founded in 2014 by Amy Edgar and subsequently relaunched as a technology-enabled platform in 2021 alongside co-founder Dr. Matt Keener.
Blackbird Health has raised $17.0M across 1 funding round.
Blackbird Health has raised $17.0M in total across 1 funding round.
Blackbird Health has raised $17.0M across 1 funding round. Most recently, it raised $17.0M Series A in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2024 | $17M Series A | Define Ventures, Chirag Shah | Dragoneer Investment Group, Mubadala, Ayman Alabdallah, Frist Cressey Ventures, GreyMatter Capital | Announced |
Blackbird Health is a neuroscience-led, technology-backed mental health provider specializing in integrated care for youth aged 2 to 26, offering virtual-first hybrid services that combine therapy, medication management, and family support to address conditions like anxiety, depression, ADHD, autism, trauma, and developmental challenges.[1][2][4][5][7] It serves families navigating fragmented pediatric mental health systems by using proprietary machine-learning algorithms to identify "Blackbird Biotypes"—symptom-linked brain feature clusters—for precise, personalized treatments, resulting in 85% of patients with depression/anxiety showing clinically significant improvement, lower medication use, and reduced ER/hospital utilization.[1][4][5] With over 10,000 patients served, 110+ specialists, and 9 clinic locations across Pennsylvania, Virginia, and New Jersey, the company demonstrates strong growth momentum, bolstered by a $17 million Series A in 2024 to scale nationwide.[1][5][7]
Blackbird Health emerged over a decade ago from the vision of co-founder Dr. Matt Keener, a child psychiatrist whose telemedicine experience highlighted gaps in pediatric mental health care, such as fragmented services and lack of developmentally informed treatments.[2][3] The company built its foundation on 10+ years of patient data (over 50 million data points) to develop computational models for better diagnostics, starting with virtual and in-person services in Pennsylvania and Virginia.[1][3] A pivotal moment came in 2023 when Tom Peterson, former Evolent Health Co-founder and COO, joined as CEO after his family's personal experience with Blackbird, steering it toward national expansion amid rising youth mental health needs.[1] Early traction included high retention rates and superior outcomes, leading to partnerships like blueBriX for efficiency and the recent Series A funding.[1][3]
Blackbird Health rides the surge in youth mental health demand, exacerbated by post-pandemic crises, where pediatric systems remain fragmented with access barriers, stigma, and siloed care.[2][3] Its timing aligns with digital health maturation—virtual care adoption, AI-driven precision medicine, and hybrid models—transforming behavioral health from reactive to proactive, data-informed interventions.[1][2][6] Market forces like insurer coverage for telehealth and investor interest in impactful medtech (e.g., $17M Series A) favor scalable solutions; Blackbird influences the ecosystem by setting benchmarks for integrated pediatric care, partnering for RCM/data analytics, and advocating early brain stimulation/social interventions.[1][3] This positions it as a leader bridging clinical expertise with tech to reduce higher-cost care utilization.
Blackbird Health is primed for nationwide scaling with its Series A fueling tech builds, service expansions, and more clinics beyond the Mid-Atlantic's 40+ providers.[1][7] Trends like AI personalization in mental health, hybrid delivery mandates, and policy pushes for youth wellness will accelerate growth, potentially capturing a slice of the $280B+ U.S. behavioral health market. Its influence may evolve from regional innovator to national standard-setter, driving ecosystem-wide efficiency if it sustains outcomes amid competition; watch for biotype tech licensing or deeper insurer integrations to cement lasting impact in accessible youth care.[1][2][3]
Blackbird Health has raised $17.0M in total across 1 funding round.
Blackbird Health's investors include Define Ventures, Chirag Shah, Dragoneer Investment Group, Mubadala, Ayman AlAbdallah, Frist Cressey Ventures, GreyMatter Capital.